NCT05010447

Brief Summary

The aim of this study is to test the feasibility of an application for smartphones based on Acceptance and Commitment Therapy (ACT) that was designed to increase treatment adaptation (i.e. learning therapy skills) and treatment utility (i.e. feedback for the patient). The use of this avatar- led application will be tested by patients with mental disorders adjunctive to their therapy. Patients will be given a smartphone for one week with the application developed specifically for this purpose. The study will be a single group design and patients will be assessed two times: before and after having tested the application. Measurements will include acceptability (adherence, utilization, utility, satisfaction) of the application, as well as patients characteristics, such as diagnostic interviews, questionnaires about symptomatology, well-being, social interactions, and an exit questionnaire when leaving the study to assess what was learned.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

August 15, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 18, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

August 18, 2021

Status Verified

August 1, 2021

Enrollment Period

5 months

First QC Date

July 7, 2021

Last Update Submit

August 17, 2021

Conditions

Keywords

Avatar-guided smartphone applicationAcceptance and Commitment TherapyMental disordersDevice feasibilityApplication feasibility

Outcome Measures

Primary Outcomes (4)

  • User Experience Questionnaire

    User Experience Questionnaire (UEQ; Laugwitz, B., Schrepp, M. \& Held, T., 2008). The UEQ is a short questionnaire using semantic differentials (word pairs with opposite meanings) to allow for fast and intuitive responses. An example item would be "attractive - unattractive". Items are scored on a 7-point Likert scale and range from full agreement with the negative term (-3) to the full agreement with the positive term (+3). Half of the items start with the positive term, the rest with the negative term. Higher sum scores indicate more positive evaluation of the app.

    once at Baseline (beginning of therapy/week 1)

  • System Usability Scale

    System Usability Scale (SUS; adapted from Brooke, 1996) embedded. SUS scores have a range of 0 to 100. A high score indicates a high system usability; and where 1 = strongly disagree and 5 = strongly agree.

    up to 3 months (from Baseline/beginning of treatment to Post/end of treatment)

  • Semi-structured User Experience Questionnaire

    Self-designed questionnaire with closed and open questions regarding the user's experience with the app. Questions were tested in a pilot and then adapted in a feedback round. They include items such as "How was your week with Virtual Coach?", "What about Virtual Coach did you like best?", "What about Virtual Coach did you like least?", etc. The Interview also includes space for open comments from the user.

    up to 3 months (from Baseline/beginning of treatment to Post/end of treatment)

  • User Adherence Meta-Variables

    Metavariables and app-usage of participants are collected automatically while the app is being used by the study participant, such as: * Number of prompts responded (where a higher number equals more adherence) * Number of prompts finished (where a higher number equals more adherence) * Number of exercises completed (where a higher number equals more adherence) * Number of additional exercises completed (where a higher number equals more adherence) * Time to complete prompts (where the average time of the sample should represent an adequate time for an adherent user to complete the prompt) * An answers typed in by the participant in the app during its usage

    up to 3 months (from Baseline/beginning of treatment to Post/end of treatment)

Secondary Outcomes (13)

  • Therapy Expectancy

    up to 3 months (from Baseline/beginning of treatment to Post/end of treatment)

  • Psychological Flexibility

    up to 3 months (from Baseline/beginning of treatment to Post/end of treatment)

  • Social Interaction

    up to 3 months (from Baseline/beginning of treatment to Post/end of treatment)

  • Disability

    up to 3 months (from Baseline/beginning of treatment to Post/end of treatment)

  • Emotion Dysregulation

    up to 3 months (from Baseline/beginning of treatment to Post/end of treatment)

  • +8 more secondary outcomes

Study Arms (1)

Study Group

EXPERIMENTAL

Participants receive the Virtual Coach App for one week at the beginning of their therapy and one week towards the end of their therapy.

Device: Virtual Coach App

Interventions

The avatar-guided app aims to deepen the user's understanding of Acceptance and Commitment Therapy (ACT) and promote application of ACT skills in every-day-life. Event-Sampling-Methodology (ESM) is used to capture the user's progress as it unfolds.

Study Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Current undergoing inpatient or outpatient psychotherapy;
  • ability to speak German or English;
  • giving informed consent.

You may not qualify if:

  • not able to take part as assessed by the clinic's medical/therapeutic staff

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Universitäre Psychiatrische Kliniken (UPK) Basel

Basel, Canton of Basel-City, 4055, Switzerland

Location

Klinik Sonnenhalde

Riehen, Canton of Basel-City, 4125, Switzerland

Location

Related Publications (4)

  • Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther. 2006 Jan;44(1):1-25. doi: 10.1016/j.brat.2005.06.006.

    PMID: 16300724BACKGROUND
  • Kashdan TB, Rottenberg J. Psychological flexibility as a fundamental aspect of health. Clin Psychol Rev. 2010 Nov;30(7):865-78. doi: 10.1016/j.cpr.2010.03.001. Epub 2010 Mar 12.

    PMID: 21151705BACKGROUND
  • Karekla M, Savvides SN, Gloster A. An Avatar-Led Intervention Promotes Smoking Cessation in Young Adults: A Pilot Randomized Clinical Trial. Ann Behav Med. 2020 Oct 1;54(10):747-760. doi: 10.1093/abm/kaaa013.

    PMID: 32383736BACKGROUND
  • Trull TJ, Ebner-Priemer UW. Using experience sampling methods/ecological momentary assessment (ESM/EMA) in clinical assessment and clinical research: introduction to the special section. Psychol Assess. 2009 Dec;21(4):457-62. doi: 10.1037/a0017653.

    PMID: 19947780BACKGROUND

MeSH Terms

Conditions

Mental Disorders

Study Officials

  • Andrew T. Gloster, Prof. Dr.

    University of Basel, Faculty of Psychology, Division for Clinical Psychology and Intevention Science

    STUDY CHAIR

Central Study Contacts

Andrew T. Gloster, Prof. Dr.

CONTACT

Victoria J. Block, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Micro-Randomized Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr., Division of Clinical Psychology & Intervention Science, University of Basel

Study Record Dates

First Submitted

July 7, 2021

First Posted

August 18, 2021

Study Start

August 15, 2021

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

August 18, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations